TERUFLEX® BLOOD BAG SYSTEM CPD/OPTISOL® SOLUTION BLOOD BAG SYSTEM

Manufacturer
Terumo Corporation | Terumo Corp. - Fujinomiya Factory
Effective date
2025-01-21
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
5
Source
legacy-cache
Hydrated at
2026-08-01 20:41:56

Label at a glance#

ProductTERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative
Active ingredientTrisodium Citrate Dihydrate, SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM, Dextrose Monohydrate, Anhydrous Citric Acid, Sodium Chloride, Mannitol, Adenine
Label structure2 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

TERUFLEX® BLOOD BAG SYSTEM
CPD/OPTISOL® SOLUTION BLOOD BAG SYSTEM

Read these instructions carefully before use. Rx ONLY.

INTENDED USE

Collection of 250 mL Whole Blood:
• From elderly, pediatric, or smaller autologous donors who may not tolerate larger blood collections.
• For blood collections as directed by a patient's physician.
• Platelets prepared from 250 mL whole blood collections can only be used for the autologous donation patient.
• Platelet preparation from a 250 mL whole blood collection are unlikely to meet the 5.5x1010 platelet concentration required by the regulations.

INSTRUCTIONS FOR BLOOD COLLECTION: Use aseptic technique
1. Confirm that all numbered tubing of each blood bag unit contains its own identical segment numbers.
2. Make a loose knot in the donor tubing approximately 10 cm from the needle.
3. Clamp donor tubing with hemastat.
4. Suspend primary bag a minimum of 60 cm below the donor's arm
5. Apply blood pressure cuff. Disinfect site of phlebotomy. Inflate blood pressure cuff to 60 mmHg.
6. Remove needle protector and perform phlebotomy. Remove hemastat to permit blood flow into primary bag.
CAUTION Do not touch needle after removing the needle protector.
7. Tape donor tubing securely to donor's arm.
8. MIX BLOOD WITH ANTICOAGULANT AT SEVERAL INTERVALS DURING COLLECTION.
9. Collect 250 mL of blood.
10. Tighten knot firmly after collection. Clamp between knot and needle. Sever donor tubing between knot and clamp. Collect pilot samples.
11. Reapply clamp to donor tubing; release blood pressure cuff and remove needle from donor's arm.
CAUTION Discard tubing/phlebotomy needle unit according to institutional procedures.
12. Immediately after collection, invert bag several times mixing blood with anticoagulant thoroughly.
13. Strip blood from donor tubing into bag, mix well, and allow tubing to refill. Seal at X marks on donor tubing to provide numbered aliquots of anticoagulated blood for testing.
CAUTION Begin sealing at needle end and work towards bag.
14.The time of addition of OPTISOL solution may vary depending on the processing option selected. Add solution under one of the following conditions.
a) After removal of plasma from freshly collected blood.
b) Within 8 hours of blood collection if platelets are prepared.
c) Within 72 hours of collection if blood is refrigerated immediately following collection.
15. Centrifuge unit to separate red cells from plasma.
16. Snap CLIKTIP (incline closure device) of primary collection bag and transfer plasma into satellite bag. Clamp transfer tubing of satellite bag.
17. Snap CLIKTIP of OPTISOL solution bag and drain contents into primary bag containing red blood cells. Seal tubing of primary bag in two places, cut between seals, and separate from satellite bag.
NOTE: For TERUFLEX double bags, seal OPTISOL solution bag tubing in two places, but between seals, and separate. Discard OPTISOL solution container.
18. Mix OPTISOL solution and red cells thoroughly. Store between 1-6oC.
19. Infuse OPTISOL red blood cells within 42 days of collection.

For further processing, use standard component processing techniques.

To open the blister package, peel the cover film back 4/5 of its length. (See Fig. 3)

After opening, unused blood bags may be stored at room temperature for 96 hours, or they may be stored for 30 days in the blister package after returning the cover film to the original position and sealing with tape to prevent possible loss of moisture.

Image Figure Sealing with tape
Image Figure Sealing with tape


CAUTIONS
• THE PACKET OF AGELESS CONTAINED IN THIS PACKAGE GENERATES HEAT UPON REMOVAL AND SHOULD BE HANDLED WITH CARE.
• DISPOSE WITH AGELESS PACKET IN TRAY.
• DO NOT DISPOSE WITH WASTES CONTAINING VOLATILE OR FLAMMABLE MATERIALS.
• DISCARD AGELESS PACKET WITHOUT OPENING.
DO NOT USE UNLESS ANTICOAGULANT IS CLEAR.
RECOMMENDED STORAGE: Room Temperature (25oC/77oF).
Avoid excessive heat and direct sunlight. Protect from freezing.

TERUMO CORPORATION
44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU, TOKYO, JAPAN
TERUMO and TERUFLX are registered in U.S. Patent and Trademark Office
by TERUMO CORPORATION.
OPTISOL and CLIKTIP are trademarks of TERUMO CORPORATION.

Issued 2/95
N-BB-OP-A3

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Tray/Case Label

TERUFLEX® BLOOD BAG SYSTEM with Blood Sampling Arm®

CPD WITH OPTISOL® RED CELL PRESERVATIVE SOLUTION
FOR COLLECTION OF 250 mL OF BLOOD

Each unit consists of a primary bag containing 35mL of Anticoagulant
CPD solution, with a  satellite bag containing 56mL of OPTISOL Red
Cell Preservative Solution.

Each 35 mL Anticoagulant CPD solution USP contains 893mg Dextrose
(monohydrate) USP, 921mg Sodium Citrate (dihydrate) USP,105mg Citric
Acid (anhydrous) USP, 77.7mg Monobasic Sodium Phosphate
(monohydrate) USP.

Each 56 mL OPTISOL Red Cell Preservative Solution contains 491mg
Sodium Chloride USP, 504mg Dextrose (monohydrate) USP, 294mg
Mannitol USP, 16,8mg Adenine USP.

STERILE, NON-PYROGENIC FLUID PATH.
DO NOT USE UNLESS ANTICOAGULANT IS CLEAR

CODE

LOT No.

EXPIRY

UNITS

DONOR NEEDLE 17G x 1 1/2˝ (1.40 x 38mm)
Rx ONLY

RECOMMENDED STORAGE: Room Temperature (15-30°C/59-86°F).
Avoid excessive heat. Protect from freezing.

After opening, unused bags may be stored for 30 days by returning cover film to original position and
sealing with tape to prevent possible loss of moisture. See Instructions For Blood Collection.

Manufactured by : TERUMO CORPORATION Tokyo, Japan
® : Registered Trademark of TERUMO CORPORATION

Rev. 07/04
B-4-B7-A4 2

Image of Representative Tray/Case Label CPD-OPTISOL 250mL
Image of Representative Tray/Case Label CPD-OPTISOL 250mL


DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AdenineACTIVE INGREDIENTJAC85A21612
Anhydrous Citric AcidACTIVE INGREDIENTXF417D3PSL2
Dextrose MonohydrateACTIVE INGREDIENTLX22YL083G2
MannitolACTIVE INGREDIENT3OWL53L36A2
Sodium ChlorideACTIVE INGREDIENT451W47IQ8X2
Sodium Phosphate, MonobasicACTIVE INGREDIENT3980JIH2SW2
Trisodium Citrate DihydrateACTIVE INGREDIENTB22547B95K2
AdenineACTIVE MOIETYJAC85A21612
Citric AcidACTIVE MOIETY2968PHW8QP2
DextroseACTIVE MOIETYIY9XDZ35W22
MannitolACTIVE MOIETY3OWL53L36A2
Phosphoric AcidACTIVE MOIETYE4GA8884NN2
SODIUM CATIONACTIVE MOIETYLYR4M0NH372
WaterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53877-00553877-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0218eb2e-2996-4bff-9b3f-b639d0a82661a9f0df1a-f45e-46dd-8a58-0e0d6e9ca60f2025-02-05Exact identifier
spl set id: a9f0df1a-f45e-46dd-8a58-0e0d6e9ca60f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.